International Journal of Women's Health and Reproduction Sciences

Home Aim and Scope Instructions to Authors Editorial Policies Editorial Board Authorship Agreement Form Open Access and Copyright

Jul 2018, Vol 6, Issue 3

CURRENT ISSUE ARCHIVE AHEAD OF PRINT / ACCEPTED ARTICLE MOST VIEWED ARTICLES NEWS RELATED LINKS

Advanced Search

For Author's & Reviewer's

Committee on Publication
Ethics (COPE) Flowchart

Recommendations for the Conduct

COPE: Reviewers

World Association of Medical Editors(WAME)

EQUATOR Resources : Reviewers

Poll

How do you find the scientific quality of the published articles on our web site?

Very good

Good

Fair

Bad

Very bad

Original Article
Predictive Factors of Antidepressant Response and Remission to Bupropion Extended-Release or Psychosexual Therapy Among Infertile Women With Sexual Dysfunction
Hajar Pasha¹, Zahra Basirat¹, Mahbobeh Faramarzi², Farzan Kheirkhah³, Soraya Khafri⁴
¹Infertility and Reproductive Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran ²Social Determinants of Health Research Center, Babol University of Medical Sciences, Babol, Iran ³Department of Psychiatry, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran ⁴Department of Public Health, Babol University of Medical Sciences, Babol, Iran
IJWHR 2018; 6: 313-320 DOI: 10.15296/ijwhr.2018.52 Viewed : 4604 times Downloaded : 2580 times. Keywords : Antidepressant, Psychotherapy, Bupropion, Response, Remission, Infertility, Predictor
Full Text(PDF) \| Related Articles
Abstract

Objectives: This study aimed to evaluate the predictive factors of antidepressant response and remission to bupropion extended-release (BUP ER) or psychosexual therapy (PST) among infertile women with sexual dysfunction (SD). Materials and Methods: As a randomized controlled clinical trial, this prospective study was carried out on 3 groups of BUP ER (n = 31), PST (n = 31), and control (n = 31) in infertile women with SD in Babol, Iran during 2014-2015. Logistic regression was used to detect predictors of antidepressant response and remission. Results: Antidepressant response and remission rates were 58.1% and 54.8 % respectively in the PST group. Of the infertile women in the BUP group, 41.9% reached response and remission by the end of the study. The results for PST contained 2 predictors: occupation in response and remission (odds ratio [OR] = 0.171, P = 0.036; OR = 0.1, P = 0.013; respectively), and frequency of sexual intercourse in response (OR = 0.124; P = 0.040). The results for BUP contained three predictors: baseline severe depression level in remission (OR = 0.044, P = 0.010), economic status in response and remission (OR = 5.850, P = 0.027), and age difference of spouses in response (P = 0.031). Conclusions: Depression screening and physician notification of demographic, reproductive and clinical predictors of antidepressant response and remission are necessary for selecting effective treatment interventions.